Disopyramide—A Review

Baines M. W. Davies J. E. Kellett D. N. Munt P. I. (1976). Some pharmacological effects of disopyramide and a metabolite. Journal of International Medical Research, 4, Supplement 1, 5

Befeler B. Castellanos A. Wells D. E. Vagueiro M. C. Yeh B. K. (1975). Electrophysiologic effects of the anti-arrhythmic agent disopyramide phosphate. American Journal of Cardiology, 35, 282

Birkhead J. S. Williams E. M. Vaughan (1977). Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods. British Heart Journal, 39, 657

Camm J. Spurrell R. A. J. (1977). An electrophysiological assessment of the effect of intravenous disopyramide in the Wolff-Parkinson-White Syndrome. Proceedings of the disopyramide (rythmodan) seminar, p. 41. London: Viking Press

Conway J. F. Bottomley K. Wakely E. J. Duff R. S. (1973). Disopyramide in cardiac arrhythmias: an initial appraisal. Journal of International Medical Research, 1, 105

Croxson R. S. (1977). A multicentre study of intravenous disopyramide in myocardial infarction Proceedings of the Disopyramide (Rythmodan)Seminar, p. 65. London: Viking Press

Danilo P. Hordof A. J. Rosen M. R. (1975). Effects of disopyramide phosphate (Norpace) on electrophysiological properties of isolated canine cardiac Purkinje fibres. American Journal of Cardiology, 35, 130

Davies G. J. Joshi P. Muir J. R. (1977). The haemodynamic and electrophysiological effects of a combination of disopyramide and acebutalol given intravenously in man. Proceedings of the Disopyramide (rythmodan) Seminar, p. 37. London: Viking Press

Edwards I. R. Martin J. F. Ward J. W. (1976). The effect of disopyramide on in vivo measurement of monophasic action potential in canine heart muscle. Journal of International Medical Research, 4, Supplement 1, 26

Hartel G. Louhija A. Konttinen A. (1973). Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion. Clinical Pharmacology and Therapeutics, 15, 551

Hillis W. S. Bremner W. F. Tweddel A. Lorimer A. R. Lawrie T. D. (1977). Some aspects of the clinical pharmacology of intravenous disopyramide after myocardial infarction. Proceedings of the Disopyramide (rythmodan) Seminar, p. 49. London: Viking Press

Hulting J. Rosenhamer G. (1976). Haemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia. Acta Medica Scandinavica, 199, 41

Jennings G. Model D. G. Jones M. B. S. Turner P. P. Besterman E. M. M. Kidner P. H. (1976). Oral disopyramide prophylaxis of arrhythmias following myocardial infarction. Lancet, 1, 51

Jones T. Nagle R. E. (1977). Intravenous disopyramide for arrhythmias after myocardial infarction. Proceedings of the Disopyramide (rythmodan) Seminar, p. 61. London: Viking Press

Karim A. (1975). The pharmacokinetics of Norpace. Angiology, 26, Supplement 1, 85

Kidner P. H. (1977). The prevention of arrhythmias following myocardial infarction. Journal of the Royal College of Physicians, 11, 352

Marrot P. K. Ruttley M. S. T. Winterbottom J. T. Muir J. R. (1976). A study of the acute electrophysiological and cardiovascular action of disopyramide in man. European Journal of Cardiology, 4/3, 303

Marshall R. J. Parratt J. R. (1977). Personal communication

Mathur P. P. Mokier C. M. (1969). A comparative study on the effects of quinidine and a newer anti-arrhythmic agent, disopyramide, on mammalian myocardial metabolism of glucose and oxidative phosphorylation. Archives International Pharmacodynamics, 178, 285

Masini G. (1970). Clinical test of disopyramide (Rythmodan) in the prophylaxis of attacks of supraventricular paroxysmal tachycardia. Minerva Medical, 61, 3748

Mizgala H. F. Huvelle P. R. (1976). Acute termination of cardiac arrhythmias with intravenous disopyramide. Journal of International Medical Research, 4, Supplement 1, 82

Nayler W. G. (1976). The pharmacology of disopyramide. Journal of International Medical Research, 4, Supplement 1, 8

Nayler W. G. (1977). Personal communication

Nayler W. G. Szeto J. (1972). Effect of verapamil on contractility, oxygen utilisation and calcium exchangeability in mammalian heart tissue. Cardiovascular Research, 6, 120

Oshrain C Arif M. Cook W. R. Laidlaw J. C. Willis P. W. (1977). A double-blind comparison of disopyramide phosphate and quinidine sulphate as anti-arrhythmic agents. Unpublished

Perrin A. Loire R. Rondelet J. (1968). Effect of disopyramide in the treatment of cardiac rhythm disorders. Cahiers Medicaux Lyonnais, 44, 1487

Rangno R. E. Warnica W. Ogilivie R. J. Kreeft J. Bridger E. (1976). Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachycardiarrhythmias. Journal of International Medical Research, 4, Supplement 1, 54

Ranney R. E. Dean R. R. Karim A. Radzialowski F. M. (1971). Disopyramide phosphate: pharmacokinetics and pharmacologic relationships of a new anti-arrhythmic agent. Archives International Pharmacodynamics, 191, 162

Reid D. S. (1977). Disopyramide and sino-atrial node function. Proceedings of the Disopyramide (rythmodan) Seminal, p. 31. London: Viking Press

Sandler G. (1977). The use of disopyramide in difficult cardiac arrhythmias due to acute ischaemic heart disease. Proceedings of the Disopyramide (rythmodan) Seminar, p. 81. London: Viking Press

Sloman J. G. Hunt D. Vohra J. Dowling J. Duffield A. (1977). Oral disopyramide in the management of cardiac arrhythmias. Medical Journal of Australia, 1, 176

Sasyniuk B. I. (1976). Panel discussion. Journal of International Medical Research, 4, Supplement 1, 39

Sasyniuk B. I. Kus T. (1976). Cellular electrophysiological changes induced by disopyramide phosphate in normal and infarcted hearts. Journal of International Medical Research, 4, Supplement 1, 20

Sekiya A. Williams E. M. Vaughan (1963). A comparison of the anti-fibrillatory actions and effects on intracellular cardiac potentials of pronethalol, disopyramide and quinidine. British Journal of Pharmacology, 21, 473

Sloman J. G. Hunt D. Vohra J. Dowling J. Duffield A. (1977). Oral disopyramide in the management of cardiac arrhythmias. Medical Journal of Australia, 1, 176

Spurrell R. A. J. Thorburn C. W. Camm J. Sowton E. Deuchar D. C. (1975). Effects of disopyramide on electrophysiological properties of specialised conduction system in man and on accessory atrio-ventricular pathway in Wolff-Parkinson-White Syndrome. British Heart Journal 37, 861

Vismara L. A. De Maria A. N. Miller R. R. Amsterdam Z. A. Mason D. T. (1975). Effects of intravenous disopyramide phosphate on cardiac function and peripheral circulation in ischaemic heart disease. Clinical Research, 23, 874

Vismara L. A. Miller R. R. De Maria A. N. Amsterdam Z. A. Vera Z. Mason D. T. (1976). The treatment of ventricular arrhythmias: evaluation of standard therapy and recent advances. Heart and Lung, 5, 485

Ward J. W. (1976). Disopyramide dose. Lancet, 1, 302

Ward J. W. Kinghorn G. R. (1976). The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimens. Journal of International Medical Research, 4, Supplement 1, 49

Whiting B. Miller S. (1977). Disopyramide pharmacokinetics relationship to bioavailability and renal impairment. Proceedings of the Disopyramide (rythmodan) Seminar, p.11. London: Viking Press

Zainal N. Kidner P. H. Carmichael D. J. S. (1977). Oral disopyramide in the prophylaxis of arrhythmias in patients with acute myocardial infarction managed in the open ward. Proceedings of the Disopyramide (rythmodan) Seminar, p. 23. London: Viking Press